EGFR and non-small cell lung carcinoma: We also revealed that co-delivery of integrin αvβ3 inhibitors and EGFR agents by MPEG-PLA nanoparticles could efficiently reverse the drug resistance induced by integrin αvβ3 and provide a promising strategy in the treatment of NSCLC.